Many of the biological processes, including the expression of inflammatory genes, DNA repair, and cell proliferation are governed 
homeostasis and pancreatic differentiation genes, are under tight regulation by histone (de)acetylation [5] [6] [7] . These studies convincingly demonstrated that glucose-induced regulation of insulin gene expression involves hyperacetylation of histone H4 at the insulin gene promoter, which is carried out by the specific recruitment of p300, a HAT, in the presence of stimulatory glucose concentrations [6] . Available data also suggest that the ␤ cellspecific transcription factor, pancreatic duodenal homeobox-1 and p300 interact with each other in isolated ␤ cells in vitro and in vivo [8] .
In [9] [10] [11] [12] . The cytotoxicity of IL-1␤ is attributed primarily to the induction of iNOS and the subsequent generation of NO [13] . Several studies have indicated that iNOS expression is under the fine control of the transcription factor NF-B [14] [15] [16] [17] [18] . [19] [20] [21] [22] [23] [23] .
the context of the current studies, it is well established that the islet ␤ cell is susceptible to autoimmune aggression by immune-mediated cells, which secrete cytokines (e.g. interleukin-1␤ [IL-1␤]) resulting in their demise via apoptotic mechanisms

Recent studies in multiple cell types, including pancreatic ␤ cells, demonstrated that NF-B-induced transcription is tightly regulated by the acetylation-deacetylation cycle of histones
. In this context, recent studies by Larsen et al. in islet ␤ cells demonstrated that inhibition of HDACs by pharmacological intervention using trichostatin A (TSA) prevents cytokineinduced ␤-cell death [23]. They further demonstrated that such an effect of TSA is due to its ability to down-regulate the NF-B transactivating activity, thus inhibiting iNOS expression and subsequent NO production
One important protein that is involved in the early signalling events of IL-1␤-mediated iNOS expression and NO release is the novel isoform of protein kinase C, PKC␦. Previously, Carpenter et al. [24] demonstrated that the activation of PKC␦ is essential for the activation of NF-B. Such conclusions were drawn primarily using adenovirus-mediated over-expression of wild-type and kinase-dead mutant forms of PKC␦. These studies demonstrated that the kinase-dead mutant form of PKC␦ significantly attenuated IL-1␤-stimulated iNOS protein expression and NO production, suggesting a key regulatory role for this kinase in IL-1␤-mediated effects on the islet ␤ cell.
Based on this existing evidence, and as a logical extension to our published [25] [26] [27] [28] and ongoing studies, we undertook the current investigation to determine the potential role of histone (de) [25, 26, 28] . Blots were then probed with an anti-serum raised against acetylated-histone H4. Immune complexes were detected using an ECL kit. The same membranes were further stripped and re-probed using rabbit polyclonal antibody raised against total histone H4. 
acetylation in IL-1␤-induced iNOS expression and NO release in insulin-secreting INS 832/13 (INS) cells. We accomplished the above objective by two independent approaches; first, through the use of sodium butyrate (NaB) or TSA to impede the functional activation of candidate HDACs, and second, using rottlerin, a known inhibitor of PKC␦, to attenuate the PKC␦ activation step in early steps of the signalling cascade, leading to iNOS expression and subsequent NO release. Our current findings implicate key regulatory roles for histone deacetylation (or hypoacetylation) in IL-1␤-mediated iNOS effects on insulinsecreting ␤ cells.
Materials and methods
Materials
Immunological localization of Class 1 and Class 2 HDACs in insulin-secreting cell lines
Protein assay
Protein concentrations were determined by the dye-binding method of Bradford using bovine serum albumin as the standard [31] .
Statistical analyses of data
Statistical significance of differences between the control and experimental groups was determined by ANOVA, and a P value less than 0.05 was considered to be significant. Fig. 3 [32] [33] [34] and down-regulates the pro-apoptotic pathways in models of autoimmune diseases [35] [24] demonstrated that PKC␦ plays a positive modulatory role in iNOS mRNA stability and cell death in islet ␤ cells [24] . observations from multiple laboratories [24, 37, 38] . Under these conditions, rottlerin also inhibited IL-1␤-induced iNOS expression (Fig. 6, 
Results
Localization of HDACs in insulin-secreting cells
We further examined localization of Class 1 HDACs in purified nuclear extracts isolated from INS cells (see Methods for additional details). Data in Fig. 1 (panel C) further support our data in Fig. 1 (panel A) to suggest immunological localization of these HDACs in nuclear extracts from INS cells. Intact INS cells and their nuclear extracts were used in all subsequent experiments described later.
HDAC inhibitors markedly attenuate IL-1␤-induced iNOS expression and in NO release in INS cells
Data in Fig. 2 (Panel A) demonstrate that sodium butyrate (NaB), a generic inhibitor of HDACs, modestly, but significantly, inhibited IL-1␤-induced NO release from these cells in a dose-dependent manner (0-1000 µM). NaB elicited no significant effects on basal NO release (Fig. 2, panel A). NaB also inhibited IL-1␤-induced iNOS expression under the conditions in which it reduced NO release (Fig. 2 B). Together, these data demonstrate that IL-1␤-induced iNOS expression and NO release may require histone deacetylation. We next examined the inhibitory potential of TSA, a more specific inhibitor of HDACs, on IL-1␤-induced NO release and iNOS expression in INS cells. Data in
Potential involvement of a PKC␦-dependent step on histone (de)acetylation in the ␤ cell
A recent study by Yuan et al. [36] demonstrated a role for PKC␦ in the inhibition of the HAT activity of the transcriptional coactivator CBP/p300 and further implicated a role for this signalling step in the inhibition of cell growth. Interestingly, in the context of IL-1␤-induced iNOS expression and NO release, Carpenter et al.
Based on these interesting findings and to further decipher potential cross-talk between these pathways, we determined the contributory roles for a PKC␦-mediated histone deacetylation step in the regulation of IL-1␤-induced iNOS expression and NO release in INS cells. For this purpose, we used rottlerin, a known inhibitor of PKC␦, to quantitate its effects on IL-1␤-induced iNOS expression and subsequent NO release in INS cells. Data in Fig. 6 (panel A) demonstrate that rottlerin significantly attenuated IL-1␤-induced NO release in a concentration-dependent manner without significantly affecting basal NO release; these findings are compatible with
Fig. 4 TSA induces a modest loss in metabolic cell viability in INS cells. INS cells were incubated in the absence or presence of IL-1␤ (600 pM; 24 hrs) as indicated in the figure. TSA (200 nM) was also present in the incubation medium as indicated in the figure. Metabolic cell viability was determined using MTT assay as described in Methods. These data indicated a modest, but significant inhibition in metabolic cell viability in INS cells. A similar degree of inhibition in metabolic cell viability was also demonstrable in these cells following incubation with IL-1␤. Loss in metabolic cell viability in these cells was not significantly different in the combined presence of IL-1␤ and TSA. Data are expressed as percent of control [mean ± SEM]. *P < 0.001 compared with control, untreated cells.
Fig. 5 TSA significantly attenuates IL-1␤-induced NO release during shorter incubation periods of exposure. INS cells were incubated in the absence or presence of IL-1␤ (600 pM; 6 or 8 hrs) as indicated in the figure. TSA (200 nM) was also present in the incubation medium (2 hrs prior to the addition of IL-1␤). NO released into the medium was quantitated using
panel B; ~36% and 51%, respectively, with 2.5 and 5 µM rottlerin). Together, these data demonstrate that IL-1␤-induced iNOS expression and NO release require a PKC␦-dependent step.
Effects of TSA or rottlerin on the acetylation status of histone H4 in INS cells
Recent studies from the laboratory of Kone [20] [20] . With Fig. 7 (panel B) . Also, please note that under these conditions, we observed inhibition of IL-1␤-induced NO release (Fig. 6,  panel A, bar 2 
have identified novel signalling pathways to further demonstrate potential roles for histone deacetylation in IL-1␤-induced iNOS expression and NO release in mesangial cells. They demonstrated that TSA attenuates IL-1␤-induced iNOS expression in these cells via phosphoinositide 3-kinase and p70s6 kinase-dependent signalling steps to increase site-specific histone H4 acetylation at the -978 to -710 region of the iNOS promoter
versus bar 6). Together these data (Figs. 6 and 7)
hrs prior to the addition of IL-1␤ (see text for additional details). Cells were harvested following 6-hrs incubation with IL-1␤ (600 pM). Total RNA was isolated using Trizol reagent, and abundance of iNOS mRNA was assessed by real-time RT-PCR (see Methods for additional details). Values shown are fold increase ± SEM (n = 3 determinations) over iNOS mRNA in control cells incubated in the absence of IL-1␤ and/or inhibitors (P < 0.001 versus IL-1␤ for all the treatment groups).
Fig. 6 Rottlerin significantly decreases IL-1␤-induced NO release and iNOS expression in INS cells. Panel A: INS cells were incubated in the absence or presence of IL-1␤ (600 pM; 24 hrs) as indicated in the figure. Rottlerin (0-5 µM) was also present in the incubation medium (30 min. prior to the addition of IL-1␤
Determination of potential HDAC inhibitory properties of rottlerin in INS cells
To test this, we quantitated HDAC activity in nuclear extracts purified from INS cells (as in Fig. 1, panel C) (Fig. 8, bar 4 versus 5) . However, rottlerin (5 µM) had no effect on HDAC activity in nuclear extracts from either cell preparation. Based on these findings, we conclude that the effects of rottlerin on histone H4 acetylation (Fig. 7) [23] . (30 min. prior [19, 49, 50] . Several mechanisms have been put forth by which acetylation of histones alter the functional regulation of transcriptional factors [39] [40] [41] [42] [43] [44] 
In the present study, we attempted to further examine putative regulatory roles for histone acetylation-deacetylation steps in IL-1␤-induced NO release in isolated ␤ cells. Our findings demonstrate that (i) members of Class 1 and Class 2 families of HDACs are localized in a variety of insulin-secreting cells, including INS cells, HIT-T15 cells and MIN6 cells; (ii) two structurally dissimilar inhibitors of HDAC (e.g. NaB and TSA) attenuated IL-1␤-induced iNOS expression and NO release; (iii) TSA elicits inhibitory effects on IL-1␤-induced iNOS mRNA levels (within 6 hrs of incubation) in these cells; (iv) in a manner similar to TSA, rottlerin, a specific inhibitor of PKC␦, also significantly attenuated IL-1␤-induced iNOS expression and NO release, while significantly augmenting histone H4 acetylation and (v) in contrast to TSA, rottlerin's effects on histone H4 acetylation are not due to its ability to inhibit HDAC activity in INS cells, at least in broken cell preparations. Based on
